187
Participants
Start Date
March 2, 2017
Primary Completion Date
October 6, 2020
Study Completion Date
October 30, 2020
Placebo Oral Capsule
Capsule containing an inert placebo
Bardoxolone Methyl
Bardoxolone methyl dose escalated from 5 mg to a maximum of 20 or 30 mg, depending on baseline proteinuria status.
Royal Brisbane and Women's Hospital, Herston
Columbia University Nephrology, New York
Nephrology Associates, PC, Flushing
University of Pittsburgh School of Medicine - Division of Pediatric Nephrology, Pittsburgh
Children's Hospital of Philadelphia (CHOP), Philadelphia
Biolab Research, LLC, Rockville
Brookview Hills Research Associates, PLLC, Winston-Salem
Duke University Medical Center, Durham
South Carolina Nephrology & Hypertension Center, Inc, Orangeburg
Hospital Virgen de la Arrixaca, El Palmar
Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta
South Florida Research Institute, Lauderdale Lakes
University of Alabama at Birmingham, Birmingham
University of Medicine Gottingen, Göttingen
CHU Grenoble- Grenoble France, La Tronche
Cleveland Clinic, Cleveland
Akron Nephrology Associates, Akron
Akron Children's Hospital, Akron
University of Cincinnati, Cincinnati
University of Michigan, Ann Arbor
University of Minnesota - Division of Pediatric Nephrology, Minneapolis
NorthShore University Health System, Evanston
Washington University School of Medicine, St Louis
Children's Research Institute - The Children's Mercy Hospital, Kansas City
CHU Lyon-Hopital Edouard Herriot, Lyon
University Children's Hospital Heidelberg, Heidelberg
Hopital Necker-Universite Paris Descartes, Paris
Renal Disease Research Institute, Dallas
Southwest Houston Research, Houston
Clinical Advancement Center, San Antonio
Denver Nephrologists PC, Denver
Boise Kidney & Hypertension Institute, Caldwell
Boise Kidney & Hypertension Institute, Meridian
Advanced Clinical Research, West Jordan
University of Utah Health, Salt Lake City
Arizona Kidney Disease and Hypertension Research Services, PLLC, Phoenix
Academic Medical Research Institute, Los Angeles
David Geffen School of Medicine at UCLA, Los Angeles
Scripps Clinic, Nephrology, La Jolla
General Clinical Research Center - Parnassus, San Francisco
University of California San Francisco - Children's Renal Center, San Francisco
Oregon Health & Science University, Portland
Tufts Medical Center, Boston
Hackensack Meridian School of Medicine, Hackensack
The Warren Alpert Medical School of Brown University, Providence
Melbourne Renal Research Group, Melbourne
John Hunter Hospital, New Lambton Heights
Sydney Children's Hospital, Sydney
The Children's Hospital at Westmead, Westmead
St Marianna University Hospital, Kawasaki
Kobe University Hospital, Kobe
Japanese Red Cross Nagoya Daini Hospital, Nagoya
JCHO Cyukyo Hospital, Nagoya
Kitano Hospital, Osaka
Saga University Hospital, Saga
Saitama Children's Medical Center, Saitama
JCHO Sendai Hospital, Sendai
Juntendo University Hospital, Tokyo
Tokyo Metropolitan Children's Medical Center, Tokyo
Puerto Rico Clinical & Translational Research Center, Rio Piedras
Servicio de Nefrologia pediatrica, Barcelona
Fundacio Puigvert, Barcelona
Royal Free Hospital, London
Lead Sponsor
Biogen
INDUSTRY